Remote expert guidance for stroke care in smaller hospitals
Tests remote expert support for acute ischemic stroke care in smaller hospitals.
Plain-language title generated from the registry record
Registry title: Telemedicine-supported Management for Acute Ischemic Stroke
Key facts
- Where
- Beijing, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a new ischemic stroke who come to a basic-level hospital within 4.5 hours of the first symptoms. It tests remote expert guidance for the hospital.
- Age
- 18 years or older
- Sex
- Women and men can join.
- Disease stage
- Acute ischemic stroke. A CT or MRI scan shows no bleeding in the brain. Symptoms started 4.5 hours ago or less.
Main reasons for not taking part
- Any reason you cannot receive a clot-dissolving drug into a vein, according to AHA/ASA guidelines
- A score above 1 on the mRS disability scale before the stroke
- No consent from the patient or their legal representative
Read by machine on 9 November 2026.
Where in China
- Xuanwu HospitalBeijing, ChinaContact: Xunming JiTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Capital Medical University
- Trial code
- NCT07302971
- Record updated
- 3 February 2026
- Original description
Telemedicine-supported stroke care can provide standardized guidance to hospitals and regions with limited medical resources, thereby improving treatment outcomes for stroke patients in these areas. While this approach has been widely adopted in many developed countries, its efficacy in guiding basic-level hospitals to manage acute ischemic stroke requires further investigation through large-scale, high-quality studies.Read full original descriptionShow less
Telemedicine-supported Management of Acute Ischemic Stroke in the Basic-level Hospitals
Telemedicine-supported stroke care can provide standardized guidance to hospitals and regions with limited medical resources, thereby improving treatment outcomes for stroke patients in these areas. While this approach has been widely adopted in many developed countries, its efficacy in guiding basic-level hospitals to manage acute ischemic stroke requires further investigation through large-scale, high-quality studies.
This study focused on patients with acute ischemic stroke who sought treatment at basic-level hospitals, aiming to investigate the efficacy and safety of treating acute ischemic stroke with telemedicine-supported management. Hospitals assigned to the experimental group received remote consultation guidance, quality control and professional training from expert teams at leading stroke centers, China National Center for Neurological Disorders. Hospitals in the control group did not receive telemedicine-supported management.
Inclusion: Hospital Inclusion Criteria:; Basic-level hospitals in China (Definition: Hospitals classified as secondary-level (Grade II) or below under China's Hospital Grading Management Standards, or hospitals located in counties/county-level cities); Equipped with an emergency department and neurology ward capable of admitting stroke patients; Equipped with CT and/or MRI capable of diagnosing AIS; Equipped with intravenous thrombolytic drugs for acute ischemic stroke; Patient Inclusion Criteria:; Age ≥ 18 years; Diagnosed with acute ischemic stroke; CT/MRI confirms absence of intracerebral hemorrhage; Onset of stroke symptoms ≤ 4.5 hours; pre-stroke mRS score ≤1; Informed consent obtained from patient or their legal representative.
Exclusion: Hospital Exclusion Criteria:; Admitting fewer than 10 patients with acute ischemic stroke per month; Currently participating in other clinical trials that may interfere with this trial; Patient Exclusion Criteria:; Presence of contraindications for intravenous thrombolysis according to AHA/ASA guidelines.